- Sponsored Content
- Downstream Processing
Less is More in mRNA Therapeutics: Developing Big Ideas in Small Scale
BPI Contributor
November 1, 2022
20 Min View
Date: Nov 1, 2022
Duration: 20 Min
Sponsored by Cytiva
This webcast features: Linda Mathiasson, Strategic Customer Lead, Cytiva.
Messenger RNA technology has changed the way therapies are developed. The overall potential of mRNA is clear, with mRNA therapeutics being developed in many research areas.
The speed and potential cost gains of mRNA technology make it an interesting technology for personalized medicine.
However, much of the current equipment used in manufacturing is repurposed from the biotech industry and is designed for much larger scales than needed for mRNA.
In this webinar, we’ll discuss the challenges associated with smaller scales.
Just fill out the form below to view the recorded webcast now.
About the Author(s)
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More
